APA (7th ed.) Citation

Harper, T. A., Bacot, S. M., Fennell, C. J., Matthews, R. L., Zhu, C., Yue, P., . . . Feldman, G. M. (2021). IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses. International journal of molecular sciences, 22(21), 11848. https://doi.org/10.3390/ijms222111848

Chicago Style (17th ed.) Citation

Harper, Taylor A., et al. "IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses." International Journal of Molecular Sciences 22, no. 21 (2021): 11848. https://doi.org/10.3390/ijms222111848.

MLA (9th ed.) Citation

Harper, Taylor A., et al. "IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses." International Journal of Molecular Sciences, vol. 22, no. 21, 2021, p. 11848, https://doi.org/10.3390/ijms222111848.